title: When topical hydrocortisone became an OTC drug in Sweden--a study of the users and their information sources.
abstract: On 1 October 1983 hydrocortisone skin ointments in Sweden were declared OTC drugs and were made available without prescription. These preparations, however, were restricted to pharmacy-only sales. The effect of this reform was studied via telephone interviews with samples of customers who had bought hydrocortisone skin ointments, both with and without prescription. The aim of the study was to analyse the reform from the user's point of view. The interviews were conducted at four points in time: before the reform, during the month after the reform, 9 months and 6 years after the change. The total sales of hydrocortisone ointments have increased in the period from 1983 to 1989, both in terms of number of packages and in weight. Most of the background variables of the OTC users did not change over time. However, the percentage of the OTC group who had university education was high at the time of the reform but decreased later. It was found that journal articles were the most frequently used source of information about preparation availability at the time of the reform. However, their importance decreased over time and pharmacy personnel and nurses had become the most important sources 6 years after the reform. Pharmacy personnel had also become the most important source on brand selection and on how to use the preparation 6 years after the reform. An individual tended to use the same source of information about availability, brand selection and how to use the preparation. Those with university education had seen and used written material more often than those without such a background.
authors.affiliation: Department of Social Pharmacy, Uppsala University, Sweden.
authors.forename: J O
authors.initials: JO
authors.lastname: Brånstad
authors.forename: I
authors.initials: I
authors.lastname: Kamil
authors.forename: J
authors.initials: J
authors.lastname: Lilja
authors.forename: M
authors.initials: M
authors.lastname: Sjöblom
mesh_terms: D000287:Administration, Topical; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000191:economics / Q000600:supply & distribution / Q000627:therapeutic use*; D016527:Drug Costs; D004346:Drug Information Services; D011307:Drug Prescriptions / Q000706:statistics & numerical data*; D004363:Drug Utilization; D004522:Educational Status; D005260:Female; D018166:Health Care Reform; D006801:Humans; D006854:Hydrocortisone; D008137:Longitudinal Studies; D008297:Male; D004366:Nonprescription Drugs / Q000191:economics / Q000600:supply & distribution / Q000627:therapeutic use*; D010353:Patient Education as Topic / Q000379:methods*; D017060:Patient Satisfaction; D012494:Sampling Studies; D013548:Sweden; D013997:Time Factors
chemical_list: D000893:Anti-Inflammatory Agents; D004366:Nonprescription Drugs; D006854:Hydrocortisone